908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
908 Devices (Nasdaq: MASS) has secured a $1.7 million order from the Ministry of Health of Ukraine for its MX908 handheld mass spectrometry device with Aero module, scheduled for priority shipment in Q1 2025.
The MX908 devices, featuring proprietary High Pressure Mass Spectrometry (HPMS) technology, will be integrated into environmental testing kits for post-war applications. The system is designed to detect and identify trace levels of hazardous materials, including explosives, chemical agents, and priority drugs.
The Aero module enhancement enables rapid detection of aerosolized threats, including chemical warfare agents, pharmaceutical-based agents, and opioid analogs, providing first responders with critical actionable information for public safety.
908 Devices (Nasdaq: MASS) ha ricevuto un ordine di 1,7 milioni di dollari dal Ministero della Salute dell'Ucraina per il suo dispositivo di spettrometria di massa portatile MX908 con modulo Aero, previsto per una spedizione prioritaria nel primo trimestre del 2025.
I dispositivi MX908, dotati di tecnologia proprietaria di Spettrometria di Massa ad Alta Pressione (HPMS), saranno integrati in kit di test ambientali per applicazioni post-belliche. Il sistema è progettato per rilevare e identificare livelli traccia di materiali pericolosi, inclusi esplosivi, agenti chimici e farmaci prioritari.
Il miglioramento del modulo Aero consente una rapida rilevazione di minacce aerosolizzate, inclusi agenti di guerra chimica, agenti basati su farmaci e analoghi degli oppioidi, fornendo ai soccorritori informazioni critiche e utilizzabili per la sicurezza pubblica.
908 Devices (Nasdaq: MASS) ha asegurado un pedido de 1,7 millones de dólares del Ministerio de Salud de Ucrania para su dispositivo de espectrometría de masas portátil MX908 con módulo Aero, programado para un envío prioritario en el primer trimestre de 2025.
Los dispositivos MX908, que cuentan con tecnología de Espectrometría de Masa de Alta Presión (HPMS) patentada, se integrarán en kits de prueba ambiental para aplicaciones postbélicas. El sistema está diseñado para detectar e identificar niveles traza de materiales peligrosos, incluidos explosivos, agentes químicos y medicamentos prioritarios.
La mejora del módulo Aero permite la detección rápida de amenazas aerosolizadas, incluidos agentes de guerra química, agentes farmacéuticos y análogos de opioides, proporcionando a los primeros respondedores información crítica y accionable para la seguridad pública.
908 Devices (Nasdaq: MASS)는 우크라이나 보건부로부터 170만 달러 규모의 주문을 확보했습니다. 이 주문은 Aero 모듈이 장착된 MX908 휴대용 질량 분석기이며, 2025년 1분기에 우선 배송될 예정입니다.
MX908 장치는 독점적인 고압 질량 분석기술(HPMS)을 특징으로 하며, 전후 환경 테스트 키트에 통합될 예정입니다. 이 시스템은 폭발물, 화학 물질 및 우선 약물을 포함한 위험한 물질의 미량을 감지하고 식별하도록 설계되었습니다.
Aero 모듈의 향상된 기능은 화학 전쟁 제제, 제약 기반 제제 및 오피오이드 유사체를 포함한 에어로졸 위협의 신속한 감지를 가능하게 하여, 응급 구조자에게 공공 안전을 위한 중요한 실행 가능한 정보를 제공합니다.
908 Devices (Nasdaq: MASS) a obtenu une commande de 1,7 million de dollars du ministère de la Santé de l'Ukraine pour son appareil de spectrométrie de masse portatif MX908 avec module Aero, prévu pour une expédition prioritaire au premier trimestre 2025.
Les appareils MX908, dotés d'une technologie de spectrométrie de masse à haute pression (HPMS) propriétaire, seront intégrés dans des kits de test environnementaux pour des applications post-conflit. Le système est conçu pour détecter et identifier des niveaux traces de matériaux dangereux, y compris des explosifs, des agents chimiques et des médicaments prioritaires.
L'amélioration du module Aero permet une détection rapide des menaces aérosolisées, y compris des agents de guerre chimique, des agents à base de médicaments et des analogues d'opioïdes, fournissant aux premiers intervenants des informations critiques et exploitables pour la sécurité publique.
908 Devices (Nasdaq: MASS) hat einen Auftrag über 1,7 Millionen Dollar vom Gesundheitsministerium der Ukraine für sein tragbares Massenspektrometer MX908 mit Aero-Modul erhalten, das für eine vorrangige Lieferung im ersten Quartal 2025 vorgesehen ist.
Die MX908-Geräte, die mit proprietärer Hochdruck-Massenspektrometrie (HPMS) Technologie ausgestattet sind, werden in Umwelttestsätzen für nachkriegsanwendungen integriert. Das System ist darauf ausgelegt, Spuren von gefährlichen Materialien, einschließlich Sprengstoffen, chemischen Agenten und prioritären Medikamenten, zu erkennen und zu identifizieren.
Die Verbesserung des Aero-Moduls ermöglicht eine schnelle Erkennung von aerosolisierten Bedrohungen, einschließlich chemischer Kriegsführungsmittel, pharmazeutischer Agenten und Opioid-Analoga, und liefert den Ersthelfern entscheidende umsetzbare Informationen für die öffentliche Sicherheit.
- Secured significant $1.7M order from Ukrainian Ministry of Health
- Contract demonstrates international market expansion and government adoption
- Order validates commercial viability of MX908 technology
- Long delivery timeline (Q1 2025) may impact revenue recognition
- Single order dependency on government contract
The devices will be part of an environmental testing kit in a post-war environment and will be used primarily to detect and identify trace substances of hazardous materials, including explosives.
The MX908 handheld device utilizes the company’s proprietary High Pressure Mass Spectrometry (HPMS) technology to detect and identify hazardous substances including chemical agents, explosives, and priority drugs at trace levels. The Aero module delivers additional capability to the MX908, enabling response teams to quickly detect and identify aerosolized threats, such as chemical warfare agents, pharmaceutical based agents and opioid analogs.
The MX908 provides first responders with actionable information when dealing with unknown threats, helping to ensure public safety. For more information about 908 Devices and the MX908, visit 908devices.com
About 908 Devices
908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in vital health and safety applications, such as the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company is headquartered in the heart of
Forward Looking Statements for 908 Devices
This press release includes “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including, without limitation, statements regarding the expected uses and capabilities of the Company’s products. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on management’s current expectations and involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including the risks outlined under “Risk Factors” and elsewhere in the Company’s filings with the Securities and Exchange Commission which are available on the SEC's website at www.sec.gov. Additional information will be made available in the Company’s annual and quarterly reports and other filings that it makes from time to time with the SEC. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as may be required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250311548405/en/
Media Contact:
Barbara Russo
brusso@908devices.com
Investor Contact:
Carrie Mendivil
IR@908devices.com
Source: 908 Devices